Skip to main content

Multiple Postdoc and Technician Positions Available at Baylor College of Medicine

 

Multiple postdoc and technician positions are available in Dr. Jin Wang’s group in the Department of Pharmacology and Chemical Biology at Baylor College of Medicine (BCM).

BCM is located in the world largest medical center and has access to enormous biomedical resources. The research in the Wang lab is highly interdisciplinary and translational. The Wang lab has both chemistry and biology operations. For chemistry work, we have 17 chemical fume hoods, 4 ISCO combiflash chromatography systems, Agilent analytical LC-MS, Agilent preparative HPLC with auto-purification, and Genevac high throughput solvent evaporation, along with convenient access to 600 and 800 MHz NMR. For biology work, we have common equipment for biochemistry, molecular and cell biology, including tissue culture hoods, RT-PCR, plate reader, and imaging plate reader, and perform animal work to evaluate the efficacy of the experimental therapeutics developed in the group. In addition, we recently acquired a state-of-the-art Thermo Orbitrap Fusion Lumos Tribrid Mass Spec with UPLC and NanoLC to perform metabolomics and proteomics studies and a high-performance computing (HPC) unit with 2X Tesla V100 GPUs for omics data analysis, molecular docking, and molecular dynamics studies. The lab is well-funded with multiple NIH grants, and government and industry-sponsored research contracts. These recruitments are mainly sponsored by a recent major drug discovery support from NIH.

The major research directions include small molecule drug discovery, and probe and sensor development for biological applications. Our small molecule drug design program includes structured based drug design (in collaboration with Dr. Hui Zheng), targeting unstructured steroid receptor coactivators and hormone receptors (PNAS 2016, in in collaboration with Dr. Bert O’Malley), anti-aging drug development (in collaboration with Dr. Meng Wang), and recent initiative in proteolysis targeting chimeras (PROTACs, Nat Comm 2020, in collaboration with Dr. Michael Wang). Our probe development effort leads to the most widely used (>100 labs worldwide) reversible-reaction based fluorescent probe for glutathione quantification in living cells (Nat Comm 2017). Along with our colleagues, we founded biotech companies to commercialize some of these research efforts.

The goal of these recruitments is to further expand our efforts in small molecule drug discovery and streamline bioactivity and ADMET testing. The candidates will gain experience not only for cutting-edge research but also drug discovery process in a biotech-like environment. The candidates will join a dynamic interdisciplinary group and should be willing and able to communicate with people from different backgrounds, including chemistry, engineering, and biology.


4X Postdoc Positions in Organic Chemistry or Medicinal Chemistry

Qualifications and Responsibilities

  1. The candidate should have a Ph.D. degree in organic chemistry or medicinal chemistry, or related fields.
  2. The candidate should have at least one first authored publication in internationally recognized journals, such as JACS, Angew, JOC, OL, and JMC etc.
  3. The candidate should be motivated, independent, creative, and energetic, and willing to step out of his/her comfort zone to learn new techniques and knowledge in biology.

Compensation and Benefits

Standard benefits for postdoc

Job Type: Full-time

Salary: following NIH postdoc salary scale and depending on qualifications; minimum $52,704 per year

Application

Applicants should fill out the online application form and email a cover letter, CV including names of three references and research summary in one PDF file to bcmwanglab2011@gmail.com DO NOT email Dr. Wang directly.


2X Research Technician Positions in Biology

Qualifications and Responsibilities

  1. The candidate should have a B.S. or M.S. degree in biology or related fields with minimum GPA 3.0. Prior research experience is not required.
  2. The candidate should be motivated, and willing to learn new techniques and knowledge in biology.
  3. The candidate will work under the direction of a senior member in the group.
  4. We prefer the candidate to be able to stay in the group for at least 2-3 years.

Compensation and Benefits

Standard benefits for faculty and staff

Job Type: Full-time

Salary: minimum $36,000 per year depending on qualifications

Application

Applicants should fill out the online application form and email a cover letter, resume including names of three references and transcripts in one PDF file to bcmwanglab2011@gmail.com DO NOT email Dr. Wang directly.

 1X Research Technician Position in Chemistry

Qualifications and Responsibilities

  1. The candidate should have a B.S. or M.S. degree in chemistry or related fields with minimum GPA 3.0. Prior research experience is not required.
  2. The candidate should be motivated, and willing to learn new techniques and knowledge in chemistry.
  3. The candidate will work under the direction of a senior member in the group.
  4. We prefer the candidate to be able to stay in the group for at least 2-3 years.

Compensation and Benefits

Standard benefits for faculty and staff

Job Type: Full-time

Salary: minimum $36,000 per year depending on qualifications

Application

Applicants should fill out the online application form and email a cover letter, resume including names of three references and transcripts in one PDF file to bcmwanglab2011@gmail.com DO NOT email Dr. Wang directly.

 

Comments

Post a Comment

Popular posts from this blog

Lysine-Targeted Covalent Inhibitors Gaining Traction

In the past decade, targeted covalent inhibitors (TCIs) has experienced a resurgence due to its sustained target engagement and improved proteome-wide selectivity. Currently, targeting cysteine residues with acrylamides and other α, β-unsaturated carbonyl compounds is the predominant strategy in TCI development. Although lysine is more prevalent than cysteine and possesses lower mutation rates, lysine has been much less frequently considered and more challenging as a residue targeted by TCIs due to its low nucleophilicity. Recently, Jack Taunton and his colleagues reveled their two related work in JACS .   Based on the co-crystal structure of Hsp90 with a reversible inhibitor PU-H71, they designed two arylsulfonyl fluorides 1 and 2 and co-incubated them with Hsp90 protein (Figure 1a, b). Mass spectrometry detected the formation of a 1:1 covalent adduct. Mutation of Lys58 to arginine abrogated the covalent modification, indicating that the TCI selectively modified Lys58 (Fig...
Post a Comment
Read more

RIPK2 PROTAC Burns up the Bridges between PK and PD

GlaxoSmithKline (GSK) previously reported a series of RIPK2 PROTACs with various E3 ligase binders (Figure 1). These PROTACs can degrade RIPK2 potently and efficiently in a concentration-dependent manner (Figure1). However, their poor solubility and high microsomal clearance limited their in vivo applications. To develop a RIPK2 degrader suitable for  in vivo  applications, the GSK group identified another IAP based RIPK2 PROTAC4 that is significantly different from PROTAC2, possessing a different RIPK2 binder, IAP ligase binder and linker (Figure2). PTROTAC4 can degrade RIPK2 in a time-dependent manner and shows reduced lipophilicity and lower clearance in hepatocytes. However, the modest binding affinity between the warhead of PROTAC4 and RIPK2 requires a high dose to reach efficient RIPK2 degradation. To address this limitation, the researchers performed extensive medicinal chemistry optimization based on PROTAC 4 and identified PROTAC 6 (Figure2), which contains an...
Post a Comment
Read more